Share

Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys



The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Ele­vidys, after three patients died from liver failure after taking it or a similar treatment.



Source link